CANCER DRIVER INTERCEPTION, Systemic Inflammation, Gut Dysbiosis, Genomic Instability, Immune System Deficiency, PRENATAL SCREENING, G-TEST, ULTRANIPT , ULTRANIPT DG, OMNIPT, Inherited Metabolic Disorder, Severe Combined Immunodeficiency, Lysosomal Storage Diseases, CANCER EARLY DETECTION, Solid Cancer, Breast and Ovary, Lung, Colon and rectum, Genome Instability, AESTHETICS STEM CELLS, Skin Rejuvenation, Face Reshaping, Breast augmentation, Buttock enhancement, Scar Reduction, Hair Loss, Female rejuvenation, Penis enlargment, HEREDITARY CANCERS DRIVERS, Endometrium, Colon, Solid Cancers, Breast and Ovary, REGENERATIVE STEM CELLS, Orthopedics, Premature Ovarian Failure, Erectile dysfunction, Anti-aging Therapy iV, Empty Nose Syndrome, Body Performance, Supportive Care, CANCER DIAGNOSIS, Colon and Rectum, Breast, Ovary and Prostate, Lung Cancer Assay, Liquid Biopsy, STEM CELL EXOSOMES, Skin Aging, Hair Loss, Orthopedics, Erectile Dysfunction, Female Rejuvenation, Body Performance, Anti-Ageing, PREVENTIVE CANCER THERAPY, Systemic Inflammation, Dysbiosis, Genomic Instability, Immune Deficiency, STEM CELL BANKING, Cord Blood Derived, Cord Tissue Derived, Adipose Tissue Derived, EXOSOME COSMETICS, X-FILL – Eye & Lip Contour, X-LIFT – Firm Facial Lifting, X-SKIN- Advanced Moisturizing, X-HAIR – Hair Loss Treatment
Skip to main content

Reliability

Menu

The largest clinical validation in the world

To date, more than 3,000,000 G-test have been performed in over 52 countries. The data obtained indicate:

- A sensitivity greater than 99% (ability to correctly identify a fetus affected by the genetic anomalies object of the test
- Very high sensitivity not only for Trisomy 21 but also for Trisomy 18 and Trisomy 13
- The lowest no call rate between existing fetal DNA tests (only in 0.069% of cases it is impossible to provide the result of the test). The other tests based on selective DNA sequencing have a no call that normally exceeds 5% (5 out of 100 analyzes do not produce a result)
- A very low percentage of false positives (less than 0.05% of cases a high risk result is not confirmed)
- A very low percentage of resampling (only in 2.8% of cases it is necessary to repeat the blood sample to obtain the result of the test)

Validation

The reliability of the G-test was validated through a study involving 146,958 pregnant women. This is the largest study ever published for the validation of a non-invasive prenatal test on fetal DNA from maternal blood.

Sensitivity and specificity data, shown in the table below, refer to 112.669 tests, carried out as part of the study, for which it was possible to obtain a diagnostic check of the result. To date, over 2,500,000 tests performed worldwide are in line with the validation study data.

Quality assured

The guarantee of reliability coming from the widest scientific validation existing makes the G-test the only one in the world through which it is possible to access an insurance coverage.

×

Information Request








    Privacy Policy (*)